Informações:
Falhas:
ID
12644
Descrição
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor; ODM derived from: https://clinicaltrials.gov/show/NCT01362985
Link
https://clinicaltrials.gov/show/NCT01362985
Palavras-chave
Versões (1)
- 07/12/2015 07/12/2015 -
Transferido a
7 de dezembro de 2015
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Acute Leukemia NCT01362985
Eligibility Acute Leukemia NCT01362985
- StudyEvent: Eligibility
Similar models
Eligibility Acute Leukemia NCT01362985
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
background disease other than lymphoma or multiple myeloma (mm)
Item
background disease other than lymphoma or multiple myeloma (mm)
boolean
C0023418 (UMLS CUI [1])
C0205394 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
C0026764 (UMLS CUI [4])
C0205394 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
C0026764 (UMLS CUI [4])
Age
Item
are younger than 18 years of age.
boolean
C0001779 (UMLS CUI [1])
received transplant using ex vivo plerixafor-mobilised cells (umbilical cord cell, peripheral blood (pb), bone marrow (bm) cell collection)
Item
received transplant using ex vivo plerixafor-mobilised cells (umbilical cord cell, peripheral blood (pb), bone marrow (bm) cell collection)
boolean
C1504389 (UMLS CUI [1])
received treatment with plerixafor alone (i.e., without granulocyte colony stimulating factor (g-csf))
Item
received treatment with plerixafor alone (i.e., without granulocyte colony stimulating factor (g-csf))
boolean
C1955474 (UMLS CUI [1])
contraindication for g-csf
Item
contraindication for g-csf
boolean
C0079459 (UMLS CUI [1])
C1301624 (UMLS CUI [2])
C1301624 (UMLS CUI [2])
transplants using plerixafor-mobilised cells from allogeneic donor
Item
transplants using plerixafor-mobilised cells from allogeneic donor
boolean
C0185085 (UMLS CUI [1])
C1955474 (UMLS CUI [2])
C0411265 (UMLS CUI [3])
C1955474 (UMLS CUI [2])
C0411265 (UMLS CUI [3])
received transplant using plerixafor-mobilised bone marrow cells
Item
received transplant using plerixafor-mobilised bone marrow cells
boolean
C0005955 (UMLS CUI [1])
C1955474 (UMLS CUI [2])
C0411265 (UMLS CUI [3])
C1955474 (UMLS CUI [2])
C0411265 (UMLS CUI [3])
routes of plerixafor administration other than subcutaneous
Item
routes of plerixafor administration other than subcutaneous
boolean
C1955474 (UMLS CUI [1])
C0205394 (UMLS CUI [2])
C1522438 (UMLS CUI [3])
C0205394 (UMLS CUI [2])
C1522438 (UMLS CUI [3])
patients whose cells do not mobilize poorly
Item
patients whose cells do not mobilize poorly
boolean
C0524864 (UMLS CUI [1])
other
Item
other
boolean
C0205394 (UMLS CUI [1])
adults diagnosed with lymphoma or multiple myeloma (mm) and have been treated with plerixafor
Item
adults diagnosed with lymphoma or multiple myeloma (mm) and have been treated with plerixafor according to the european union (eu) label.
boolean
C0001675 (UMLS CUI [1])
C0024299 (UMLS CUI [2])
C0026764 (UMLS CUI [3])
C1955474 (UMLS CUI [4])
C0024299 (UMLS CUI [2])
C0026764 (UMLS CUI [3])
C1955474 (UMLS CUI [4])